|
TPX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.219800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.456800E-01 |
| Normal-vs-Stage2 |
8.802600E-01 |
| Normal-vs-Stage3 |
3.635000E-01 |
| Normal-vs-Stage4 |
5.908300E-02 |
| Stage1-vs-Stage2 |
3.148100E-02 |
| Stage1-vs-Stage3 |
9.398200E-01 |
| Stage1-vs-Stage4 |
8.349700E-02 |
| Stage2-vs-Stage3 |
8.300200E-02 |
| Stage2-vs-Stage4 |
5.544600E-03 |
| Stage3-vs-Stage4 |
1.179840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.112200E-01 |
| Normal-vs-AfricanAmerican |
5.588600E-01 |
| Normal-vs-Asian |
5.086200E-01 |
| Caucasian-vs-AfricanAmerican |
7.263400E-01 |
| Caucasian-vs-Asian |
3.751400E-01 |
| AfricanAmerican-vs-Asian |
8.536200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.174800E-01 |
| Normal-vs-Female |
3.879200E-01 |
| Male-vs-Female |
3.556800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.721820E-01 |
| Normal-vs-Age(41-60Yrs) |
9.502600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.599800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.671600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.421500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.048600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.400500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.333450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.357200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.923600E-01 |
| Classical-VS-Follicular |
2.681500E-03 |
| Classical-VS-Other |
8.304300E-02 |
| Classical-VS-Normal |
1.926220E-01 |
| Tall-VS-Follicular |
8.335300E-03 |
| Tall-VS-Other |
5.727600E-02 |
| Tall-VS-Normal |
1.157640E-01 |
| Follicular-VS-Other |
8.972000E-01 |
| Follicular-VS-Normal |
8.202200E-01 |
| Other-VS-Normal |
9.130200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.529400E-01 |
| Normal-vs-N1 |
5.319600E-01 |
| N0-vs-N1 |
8.978400E-01 |
|
|
